Clinical Trials Directory

Development of Vitamin D as a Therapy for Breast Cancer - Phase II

This study will assess whether levels of vitamin D impact the characteristics of a woman's breast cancer at diagnosis, and whether a short course of vitamin D in women with low levels of vitamin D changes the gene expression of their breast cancers.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • drug : Vitamin D

Phase: Phase 2


Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

- Women undergoing core needle biopsy for a breast abnormality suspicious for breast cancer. Women who have undergone a core needle biopsy demonstrating breast cancer who have not yet had any further therapy are also eligible so long as their core needle biopsy is available for analysis. - No prior therapy for breast cancer. - Age 18 years or older. - Ability to understand and the willingness to sign a written informed consent document. - Signed informed consent

External Links

Explore related trials

Contact information

Primary Contact:

Charlene Kranz 6504987977

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: